EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $67,700,000 | +25.6% | 853,285 | +10.8% | 0.01% | +9.1% |
| Q3 2016 | $53,891,000 | +237.4% | 769,869 | +87.0% | 0.01% | +175.0% |
| Q2 2016 | $15,971,000 | -3.6% | 411,735 | +0.6% | 0.00% | 0.0% |
| Q1 2016 | $16,574,000 | -52.5% | 409,234 | +4.1% | 0.00% | -50.0% |
| Q4 2015 | $34,856,000 | +130.2% | 393,097 | +92.2% | 0.01% | +100.0% |
| Q3 2015 | $15,139,000 | -8.9% | 204,499 | -0.5% | 0.00% | 0.0% |
| Q2 2015 | $16,615,000 | +4366.4% | 205,479 | +2215.0% | 0.00% | – |
| Q1 2015 | $372,000 | +644.0% | 8,876 | +174.7% | 0.00% | – |
| Q4 2014 | $50,000 | -95.0% | 3,231 | -95.9% | 0.00% | – |
| Q1 2014 | $1,003,000 | – | 78,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |